Bispecific antibodies for use in treatment of hidradenitis suppurativa

The present invention relates to a bivalent bispecific monoclonal antibody (bbmAb), or a variant thereof, for use in treating or alleviating the symptoms of hidradenitis suppurativa in a subject. 本发明涉及二价双特异性单克隆抗体(bbmAb)或其变体，用于在受试者中治疗或减轻化脓性汗腺炎的症状中使用。...

Full description

Saved in:
Bibliographic Details
Main Authors RODRIGUEZ MAXIMILIANO, WALDRON-LYNCH FREDRICK, BECK STEFAN, LOSCHE CHRISTIAN, KEEFE MICHAEL, KOVARIK, JOHN, TANG YU, STEIN ROBERT
Format Patent
LanguageChinese
English
Published 12.01.2024
Subjects
CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a bivalent bispecific monoclonal antibody (bbmAb), or a variant thereof, for use in treating or alleviating the symptoms of hidradenitis suppurativa in a subject. 本发明涉及二价双特异性单克隆抗体(bbmAb)或其变体，用于在受试者中治疗或减轻化脓性汗腺炎的症状中使用。
Bibliography:Application Number: CN202280036127